Back to all studies
RecruitingNCT05480150

Chinese Longitudinal and Systematic Study of Bioplar Disorder

This recruiting study focuses on bipolarity and currently lists sites or participation links in China.

BipolarityOtherFrom 16 Years to 65 Years
In plain English

Key information made simple

This study exists to learn from real-world information that can show how the medication Bioplar fits into care. Researchers are trying to understand what the medication Bioplar can reveal about signals in the brain or body that may guide care later on. For people living with Bipolarity, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including The First Affiliated Hospital of Zhejiang University in Hangzhou. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis, while common reasons not to take part include active substance or alcohol problems that could affect the results and safety concerns that need urgent care first. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT05480150. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in China.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com